MIT-Takeda program launches
Research projects will harness the power of artificial intelligence to positively impact human health.
Research projects will harness the power of artificial intelligence to positively impact human health.
Data-informed efforts are contributing to the Institute’s ramp-up strategy.
Engineers design nanoparticles that stimulate the immune system, helping it to attack tumors.
Chemical process called ELAST allows labeling probes to infuse more quickly, and makes samples tough enough for repeated handling.
Multi-institutional MassCPR initiative announces more than $16.5 million to support 62 Boston-area projects.
Students around the country recognized for innovative solutions to better single-use plastic, spacecraft and aircraft fuel gauges, surgery techniques, and more.
Inaugural AI Powered Drug Discovery and Manufacturing Conference drew pharmaceutical companies, government regulators, and pioneering drug researchers.
Professor of chemistry and IMES core member is recognized for his leadership and pioneering spirit.
The Audacious Project commitment will support the development of new classes of antibiotics to treat the world’s deadliest bacterial pathogens.
Study finds specific cells in the lungs, nasal passages, and intestines that are more susceptible to infection.
The $90,000 merit-based fellowship funds graduate studies for outstanding immigrants and children of immigrants.
Nuclear scientists and biomedical researchers team up to investigate whether treatment with gamma radiation could make N95 masks more reusable.
A team from MIT has designed disposable face shields that can be mass produced quickly to address hospitals’ needs nationwide.
Chemical engineers have developed a way to protect transplanted drug-producing cells from immune system rejection.
Labs across campus respond to a call; MIT sends thousands of items directly to area hospitals in need.